EUVIMEDEUVIMED entdecken
Open Access

Discovery of novel BCAT2 inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies

Dong Xu iD, Wenxiu Weng, Huining Cao, Chao Zhang, Yudi Zhang, Yan Li, Junhai Xiao, Hua Xie, Jialin Guo, Guoliang Chen iD

RSC Medicinal Chemistry · 2026 · 17 (5) · 2549-2565

DOI: 10.1039/d6md00019c ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von Dong Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical Uni…. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Structure-based rational design yielded novel potent BCAT2 inhibitors C10 (IC 50 = 44 nM) and C11 (IC 50 = 54 nM), which exhibit 8–10-fold selectivity over BCAT1 and form stable, key interactions within the BCAT2 active pocket.

Autor:innen und Institutionen

  • Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University Shenyang 110016 China spucgl@163.com.
  • National Engineering Research Center for the Emergency Prevention and Control Drugs Beijing 100039 China shandongguojialin@163.com.
  • Academy of Military Medical Sciences Beijing 100850 China.
  • Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Zhongshan 528400 China hxie@simm.ac.cn.
  • Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai 201203 China.

ORCID-Profile: Dong Xu, Guoliang Chen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xu, D., Weng, W., Cao, H., Zhang, C., Zhang, Y., Li, Y., Xiao, J., Xie, H., Guo, J., & Chen, G. (2026). Discovery of novel BCAT2 inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies. RSC Medicinal Chemistry, 17(5), 2549-2565. https://doi.org/10.1039/d6md00019c

Vancouver

Xu D, Weng W, Cao H, Zhang C, Zhang Y, Li Y, et al. Discovery of novel BCAT2 inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies. RSC Medicinal Chemistry. 2026;17(5):2549-2565. doi:10.1039/d6md00019c

BibTeX
@article{Xu2026,
  author = {Xu, Dong and Weng, Wenxiu and Cao, Huining and Zhang, Chao and Zhang, Yudi and Li, Yan and Xiao, Junhai and Xie, Hua and Guo, Jialin and Chen, Guoliang},
  title = {Discovery of novel BCAT2 inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies},
  journal = {RSC Medicinal Chemistry},
  year = {2026},
  volume = {17},
  number = {5},
  pages = {2549--2565},
  doi = {10.1039/d6md00019c}
}
Kostenlos starten →